Biophore, an established pharmaceutical company, is engaged in the development and manufacturing of niche pharmaceutical products for the generic industry. Within a decade since inception in 2007, Biophore has emerged as a trusted partner in the generic industry across US, Europe and other regulated markets.
Biophore is dedicated to consistently deliver complex & niche pharmaceutical products that exceed customer expectations and provide a rewarding work environment.
Biophore’s product range is diverse and balanced with NCE-1, Branded products and grandfather products.
Biophore’s portfolio is spread across 30 therapeutic segments and specialize in development and manufacturing of pharmaceutical actives for Oncology medications, Contrast and Diagnostic media.
For updated list of products, send an email to firstname.lastname@example.org
Disclaimer: Products under patent protection will not be sold until expiration of patent in Buyer's country or country of end use. Purchase of any patented product will be sole responsibility of the Buyer.VIEW DMF FILED PRODUCTS
|20||DOTA (for Gd-DOTA)|
Research and innovation is the mainstay of Biophore’s operations. The state-of-the-art technology development center located in Hyderabad is equipped with infrastructure that facilitates activities from conceptualization till regulatory submissions.
Biophore’s research activities extend from the development of active pharmaceuticals to fixed dose formulations for the regulated markets. At any point in time, Biophore’s research is focused on an average of 80 products which are at various stages of development.
Biophore has filed more than 100 DMFs and 150 patents for its unique portfolio.
Biophore's advanced research and development facilities have the competency to develop and commercialize processes for active pharmaceutical ingredients and fixed dose formulations. With over 80,000 square feet workspace, the research center hosts equipment up-to-date with the advancements in the field of pharmaceutical technology.
The technology development center has dedicated laboratories for development of peptides, oncology products and other potent APIs. The research center integrates the science of chemistry with innovative approach and fosters the technology to produce cost-effective and niche pharmaceutical products.
Biophore believes innovation is a component of success for any organization that banks on research. Research at Biophore compliments science with innovation and creates a “technology based approach” to develop novel and non-infringing products. Biophore respects the innovative approach and ensures every innovation is reinforced with intellectual property.
Biophore filed around 150 patents in the areas of non-infringing processes and polymorphs showcasing the devotion towards the pharmaceutical sciences.
Biophore’s manufacturing facilities are state-of-the-art, multipurpose facilities that comply with cGMP standards and meet the requirements of US and EU Drug regulatory authorities. These facilities, located in Visakhapatnam are US FDA and EU inspected and approved units.
These facilities host units customized for each category of products like peptides, hormones, colored APIs, oncology and high potent drugs products.
Biophore is committed to ensure a safe and healthy work environment to its employees, contractors, vendors and customers. Located within the exclusive pharmaceutical manufacturing area, Biophore’s facilities remain compliant with all statutory laws and regulations. We conduct periodic safety audits on all our processes to mitigate any risks to the community.
We are very well aware of what people can achieve when inspired and therefore, at Biophore, we strive to create an atmosphere for Biophoreans to excel at what they do.
We love to get better at what we do, at how we think. We love to learn. We love to grow. We are Biophore!
To be the most trusted R & D company in the complex and niche pharmaceutical molecule segments and achieve superior Customer Satisfaction through
THE CORE VALUES THAT EMBODIES THE BIOPHORE DNA ARE: